Table 1.
Demographic, baseline clinical characteristics, predictor variables.
| Symptomatic Remission | ||||
|---|---|---|---|---|
| Characteristic | Total | No | Yes | P (E.S) |
| Remission last available obs. % (n) | 186 | 58.6 (109) | 41.4 (77) | |
| Demographics (α = 0.025) | ||||
| Age of onset (SD) | 26.92 (10.76) | 26.21 (10.38) | 27.94 (11.26) | 0.283 (0.160) |
| Female % (n) | 45.2 (84) | 59.5 (50) | 40.5 (34) | |
| Male % (n) | 54.8 (102) | 57.8 (59) | 42.2 (43) | 0.979 (0.004) |
| Clinical status (α = 0.005) | ||||
| GAF Symptom mean (SD) | 31.82 (7.12) | 32.06 (6.85) | 31.50 (7.11) | 0.554 (0.079) |
| GAF Function mean (SD) | 41.10 (10.84) | 40.28 (10.14) | 42.23 (11.69) | 0.175 (0.184) |
| PANSS mean item score (SD) | ||||
| Negative | 2.15 (1.07) | 2.18 (1.00) | 2.10 (1.16) | 0.602 (0.078) |
| Disorganized | 2.02 (1.05) | 1.93 (0.91) | 2.09 (1.14) | 0.158 (0.213) |
| Depressive | 3.26 (1.04) | 3.31 (1.07) | 3.20 (1.01) | 0.453 (0.112) |
| Positive | 3.16 (0.82) | 3.19 (0.86) | 3.11 (0.75) | 0.523 (0.095) |
| Excitative | 1.58 (0.73) | 1.53 (0.67) | 1.65 (0.80) | 0.288 (0.159) |
| Total | 64.69 (14.25) | 64.39 (11.62) | 65.13 (17.39) | 0.727 (0.053) |
| aSubstance abuse % (n) | 24.2 (45) | 60.00 (27) | 40.00 (18) | 0.630 (0.064) |
| bDUP weeks median (Range, SD) | 20.00 (0–2080, 221,05) | 30.00 (0–2080, 264.17) | 13.50 (0–572, 135.17) | 0.010 (0.253) |
| cCore schizophrenia % (n) | 32.30 (60) | 63.3 | 36.7 | 0.143 (0.193) |
| Predictor variables (α = 0.008) | ||||
| d Social satisfaction (SD) | ||||
| Family | 4.78 (1.36) | 4.61 (1.47) | 5.02 (1.15) | 0.040 (0.309) |
| Friends | 4.617 (1.25) | 4.45 (1.32) | 4.85 (1.11) | 0.029 (0.328) |
| Social satisfaction total | 4.69 (1.22) | 4.52 (1.12) | 4.92 (0.83) | 0.008(0.404) |
| eSocial frequency (SD) | ||||
| Family | 4.12 (0.84) | 4.05 (0.92) | 4.21 (0.71) | 0.178 (0.203) |
| Friends | 3.41 (1.05) | 3.23 (1.13) | 3.67 (0.88) | 0.005 (0.428) |
| Social frequency total | 3.69 (0.77) | 3.56 (0.83) | 3.88 (0.62) | 0.004 (0.441) |
aTransformed to binary variables: Abuse defined as score of >2 measured by the Clinicians Rating Scale.
bDUP: p-value and effect size is based on log-transformed DUP.
cSchizophrenia spectrum disorders: Schizophrenia, Schizophreniform, and Schizoaffective disorder.
d/eVariables from Lehman quality of life interview. ∗Bonferroni adjusted α levels for each section of the table. E.S: Effect size (Cohen’s D).
Bold values indicate statistically significant values.